Question 1

Which is bigger, ABBV or TMO?

Accepted Answer

Abbvie Inc. is the larger company — market cap $488B vs $243B for Thermo Fisher Scientific, Inc..

Question 2

Which is more profitable, ABBV or TMO?

Accepted Answer

TMO keeps more of each revenue dollar as profit — net margin 15.0% vs 9.8% for ABBV.

Question 3

Which stock is cheaper, ABBV or TMO?

Accepted Answer

On earnings, TMO trades at a lower P/E — 34.9 vs 77.4 for ABBV. A lower P/E means paying less per dollar of earnings.

Question 4

Which pays a higher dividend, ABBV or TMO?

Accepted Answer

ABBV yields 2.45% vs 0.27% for TMO.

Question 5

Which is the better stock — ABBV or TMO?

Accepted Answer

On reported financials, ABBV leads 5 of 11 comparable metrics and TMO leads 6. StockCV rates ABBV “Mixed” and TMO “Mixed”. This is information, not investment advice — compare the full CVs before drawing conclusions.

Metric	ABBV	TMO
Price	$276.43	$658.02
Market cap	$488B	$243B
Revenue (TTM)	$64.4B	$46.3B
Revenue growth	+1.8%	-0.3%
Net margin	9.8%	15.0%
Free cash flow	$18.2B	$7.32B
Net cash (debt)	($56.2B)	($29.3B)
1-year price return	+19.8%	+23.1%
P/E	77.4	34.9
P/E vs own history (cheap-side %)	23%	24%
Dividend yield	2.45%	0.27%
Return on equity	96%	13%
Altman Z-score	2.33	—
CV checks passed	9 of 11	10 of 11
Employees	57,000	125,000

Abbvie Inc. vs Thermo Fisher Scientific, Inc.